Immunoaugmentative Therapy + Tirbanibulin
Tirbanibulin brand name: Klisyri.
We found no known interaction between Immunoaugmentative Therapy and Tirbanibulin in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first. Additionally, although there is no interaction, the two are separately associated with some of the same side effects, which would make a new symptom harder to attribute to one or the other.
Immunoaugmentative Therapy and Tirbanibulin
We checked these two against our interaction database. Here is what we found.
No Known Interaction Found
We did not find a documented interaction between Tirbanibulin and Immunoaugmentative Therapy in our sources. This does not guarantee that the combination is completely free of risk — research on Immunoaugmentative Therapy alongside specific medications may be limited.
Worth understanding: our licensed dataset holds no drug-interaction record for Immunoaugmentative Therapy at all — not against Tirbanibulin, and not against any other medication we track. This verdict therefore rests on the absence of any recorded data, not on research that looked at this combination and found nothing. We cannot rule an interaction out.
Immunoaugmentative Therapy is a treatment rather than something you take. Tell whoever provides it which medicines you use, and ask your prescriber whether it is appropriate for your health and treatment. Do not stop a prescribed medicine on your own.
Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.
Immunoaugmentative Therapy safety at a glance
Safety guidance is general; always confirm with your pharmacist or doctor for your situation.
What Tirbanibulin Is Prescribed For, and What Immunoaugmentative Therapy Has Been Studied For
These two come up together because they touch the same health topic — not because they do the same job. Tirbanibulin is a prescription medicine with approved uses on its FDA label. Immunoaugmentative Therapy is a treatment: what follows is what researchers have looked at it for, and how strong that evidence is.
Tirbanibulin is prescribed for: Klisyri (tirbanibulin 1% ointment) is applied directly to the skin to treat actinic keratosis — rough, scaly patches caused by years of sun damage that can sometimes turn into skin cancer if left untreated. It is approved for use on the face or balding scalp in adults. Klisyri is applied to the entire affected treatment area (up to a 100 cm² patch) rather than to individual spots, an approach called field treatment.
Immunoaugmentative Therapy has been studied for:
-
Cancer studied, not established Immunoaugmentative Therapy has been studied for this. Natural Medicines rates the evidence: Insufficient Reliable Evidence To Rate Read what the research shows
Immunoaugmentative Therapy for cancer
A retrospective evaluation of 46 cancer patients consecutively treated at an immunoaugmentative therapy clinic in Mexico suggests that this therapy does not alter the course of cancer or provide any measurable benefits. The validity of this finding is limited by the retrospective nature of the chart review.
Effectiveness ratings and the research summaries above are the verbatim record from the Natural Medicines database, which grades evidence from “Effective” down to “Insufficient Reliable Evidence To Rate”. A rating below the top of that scale means researchers have looked at it — not that it works, and never that it can stand in for a prescribed medicine. Do not stop or replace Tirbanibulin on your own; if you are taking Immunoaugmentative Therapy for the same health topic, tell your prescriber, especially if the medicine is being adjusted to a target.
See Every Supplement That Interacts With Tirbanibulin
This page covers Immunoaugmentative Therapy only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Tirbanibulin page lists 3 supplements it has a documented interaction with, worst first, each one explained.
The most serious there right now: Dimethylsulfoxide (dmso) (moderate), Turpentine Oil (moderate) and Alchemilla (minor).
By severity: 2 moderate · 1 minor.
From our pharmacist’s overview on the Tirbanibulin page
“Topical DMSO is the one to know about if you use tirbanibulin (Klisyri), the ointment prescribed for actinic keratosis on the skin. DMSO can drive other topical drugs deeper through the skin, which could amplify both the medication's effect and its irritation right where it's applied.”
Reviewed by 2 · Jul 18, 2026
Where Immunoaugmentative Therapy and Tirbanibulin Sit Against Everything Else
Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.
#632 of 1,452 supplements looked up here in the last 7 days
#2,761 of 2,830 medications looked up here in the last 7 days
Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.
Where does our data come from?
- Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
- Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Immunoaugmentative Therapy reference on this page ↓
- Freshness: we automatically re-check this combination every week — this pair was last verified September 13, 2026. The Immunoaugmentative Therapy and Tirbanibulin records this page draws on were last updated July 10, 2026.
- What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
About Immunoaugmentative Therapy
What is Immunoaugmentative Therapy?
- Cancer (as an alternative therapy)
- Attempts to boost the immune system
- Tumor reduction claims
Immunoaugmentative Therapy (IAT) is an unproven alternative cancer treatment, not a dietary supplement or herb. It involves injecting blood-derived protein mixtures, but there is no reliable scientific evidence that it treats cancer or any other disease, and it carries real safety risks. Talk to your oncologist before considering any alternative cancer therapy.
Not applicable (this is a treatment procedure, not a plant or herb) · Injections of blood-derived protein fractions given at a treatment clinic
An interaction check asks whether these two react with each other — it does not ask whether Immunoaugmentative Therapy is a good idea for someone in your situation. Here is what our Immunoaugmentative Therapy record says about it on its own.
Immunoaugmentative Therapy: dosing
There is no established or standardized dose for Immunoaugmentative Therapy, and it is not a product you can buy as a supplement. It was administered only at specific clinics following protocols that were never validated by mainstream science.HelloPharmacist does not recommend IAT.
From our Immunoaugmentative Therapy monograph — the full record covers uses, side effects and every documented interaction.
About Tirbanibulin Topical
What Is Tirbanibulin Topical Used For?
Brand name: Klisyri
Klisyri (tirbanibulin 1% ointment) is applied directly to the skin to treat actinic keratosis — rough, scaly patches caused by years of sun damage that can sometimes turn into skin cancer if left untreated. It is approved for use on the face or balding scalp in adults.
Klisyri is applied to the entire affected treatment area (up to a 100 cm² patch) rather than to individual spots, an approach called field treatment.
Other Drugs & Immunoaugmentative Therapy
Browse every other medication we’ve checked against Immunoaugmentative Therapy — both the ones with a known interaction and the ones without. Select any drug for the full detail.
No drugs match “”.
No interaction 2,829 drugs checked — show the list
We also checked Immunoaugmentative Therapy against these medications and found no known interaction in our sources. Open any page to confirm.
- Apixaban ›
- Levothyroxine ›
- Amlodipine ›
- Methylphenidate ›
- Warfarin ›
- Sertraline ›
- Testosterone ›
- Losartan Potassium ›
- Metoprolol ›
- Aspirin ›
- Ivermectin ›
- Rivaroxaban ›
- Rosuvastatin ›
- Escitalopram ›
- Tadalafil ›
- Acetaminophen ›
- Clopidogrel ›
- Atorvastatin ›
- Valacyclovir ›
- Docusate ›
- Hydroxyurea ›
- Abemaciclib ›
- Ibuprofen ›
- Methamphetamine ›
- Semaglutide ›
- Sumatriptan ›
- Tirzepatide ›
- Warfarin Sodium ›
- Prednisone ›
- Propranolol ›
- Lisdexamfetamine ›
- Bupropion ›
- Metformin ›
- Amoxicillin ›
- Acyclovir ›
- Lisinopril ›
- Bendamustine ›
- Amitriptyline ›
- Doxycycline ›
- Lamotrigine ›
- Fluoxetine ›
- Methotrexate ›
- Pregabalin ›
- Gabapentin ›
- Amphetamine ›
- Acetaminophen, Codeine ›
- Isotretinoin ›
- Azithromycin ›
- Dextroamphetamine ›
- Clonazepam ›
- Omeprazole ›
- Quetiapine ›
- Methylene Blue ›
- Amlodipine Besylate ›
- Duloxetine ›
- Letrozole ›
- Buspirone ›
- Citalopram ›
- Ciprofloxacin ›
- Naproxen ›
Showing the 60 most looked-up of 2,829 medications checked with no known interaction — see the full Immunoaugmentative Therapy list.
Immunoaugmentative Therapy References
The 3 references that drive our Immunoaugmentative Therapy monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.
- Pfeifer BL, Jonas WB. Clinical evaluation of "immunoaugmentative therapy (IAT)": an unconventional cancer treatment. Integr Cancer Ther. 2003;2(2):112-9. PubMed
- Green S. Immunoaugmentative therapy. An unproven cancer treatment. JAMA 199313;270(14):1719-23. DOI
- Questionable Methods of Cancer Management: Immuno-augmentative Therapy (IAT). CA Cancer Journal for Clinicians1991;41(6):357-64.
Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.
Having Immunoaugmentative Therapy While Taking Tirbanibulin: Common Questions
Is it safe to have Immunoaugmentative Therapy while taking Tirbanibulin?
Do Immunoaugmentative Therapy and Tirbanibulin have any of the same side effects?
Are Immunoaugmentative Therapy and Tirbanibulin used for the same thing?
Does Tirbanibulin interact with any supplements?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Keep Exploring
Still Have a Question About Tirbanibulin and Immunoaugmentative Therapy?
Our pharmacists answer your medication & supplement questions — free.
This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.